Cargando…
Cas9-AAV6 gene correction of beta-globin in autologous HSCs improves sickle cell disease erythropoiesis in mice
CRISPR/Cas9-mediated beta-globin (HBB) gene correction of sickle cell disease (SCD) patient-derived hematopoietic stem cells (HSCs) in combination with autologous transplantation represents a recent paradigm in gene therapy. Although several Cas9-based HBB-correction approaches have been proposed, f...
Autores principales: | Wilkinson, Adam C., Dever, Daniel P., Baik, Ron, Camarena, Joab, Hsu, Ian, Charlesworth, Carsten T., Morita, Chika, Nakauchi, Hiromitsu, Porteus, Matthew H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7846836/ https://www.ncbi.nlm.nih.gov/pubmed/33514718 http://dx.doi.org/10.1038/s41467-021-20909-x |
Ejemplares similares
-
Highly efficient editing of the β-globin gene in patient-derived hematopoietic stem and progenitor cells to treat sickle cell disease
por: Park, So Hyun, et al.
Publicado: (2019) -
Priming Human Repopulating Hematopoietic Stem and Progenitor Cells for Cas9/sgRNA Gene Targeting
por: Charlesworth, Carsten T., et al.
Publicado: (2018) -
Cas9-AAV6-engineered human mesenchymal stromal cells improved cutaneous wound healing in diabetic mice
por: Srifa, Waracharee, et al.
Publicado: (2020) -
Multiplexed genetic engineering of human hematopoietic stem and progenitor cells using CRISPR/Cas9 and AAV6
por: Bak, Rasmus O, et al.
Publicado: (2017) -
Sox6 Directly Silences Epsilon Globin Expression in Definitive Erythropoiesis
por: Yi, Zanhua, et al.
Publicado: (2006)